UBE2D1
UBE2D1 (ubiquitin conjugating enzyme E2 D1, also known as UbcH5A, UBCH5, UBC4/5, E2(17)KB1 and SFT) is an E2 enzyme that accepts ubiquitin from the E1 complex and catalyses its attachment to substrate proteins. It contributes to the degradation of short-lived and abnormal proteins. Browse Assay Genie's current range of UBE2D1 research reagents below, or read on for the biology behind the target.
UBE2D1 acts in the middle tier of the ubiquitination cascade. Ubiquitination involves at least three classes of enzymes: ubiquitin-activating enzymes (E1s), ubiquitin-conjugating enzymes (E2s) and ubiquitin-protein ligases (E3s). UBE2D1 accepts ubiquitin from the E1 complex and catalyses its covalent attachment to other proteins, working with E3 ligases. In vitro it catalyses 'Lys-48'-linked polyubiquitination, though it lacks inherent specificity for any particular lysine residue of ubiquitin. This modification targets abnormal or short-lived proteins for degradation.
Reported substrates and partners include p53/TP53, whose ubiquitination it mediates in the E6/E6-AP-induced pathway, and the hypoxia-inducible transcription factor HIF1alpha. It also mediates ubiquitination of PEX5 and polyubiquitination of CYP3A4, and drives auto-ubiquitination of STUB1, TRAF6 and TRIM63/MURF1. In vitro it ubiquitinates STUB1-associated HSP90AB1. UBE2D1 is also essential for viral activation of IRF3. The protein is found in the cytoplasm and belongs to the ubiquitin-conjugating enzyme family; the HGNC places the UBE2D1 gene in the group of ubiquitin conjugating enzymes E2.
The enzyme is closely related to a stimulator of iron transport (SFT), which explains the alias SFT and the previous name 'stimulator of Fe transport'. It is up-regulated in hereditary hemochromatosis. Two transcript variants encoding different isoforms have been found. Mouse and rat both carry an orthologous gene, Ube2d1, so the target can be studied in common rodent models.
UBE2D1 accepts ubiquitin from E1 and mediates selective degradation of short-lived and abnormal proteins, making it a useful E2 for studying ubiquitin conjugation.
UBE2D1 functions in E6/E6-AP-induced ubiquitination of p53/TP53, linking it to tumour-suppressor protein turnover.
The enzyme participates in ubiquitination of HIF1alpha through interactions with E1 and E3 ligases, relevant to hypoxia-response research.
UBE2D1 is up-regulated in hereditary hemochromatosis and is essential for viral activation of IRF3, connecting iron biology and antiviral signalling.
UBE2D1 is an E2 ubiquitin-conjugating enzyme. It accepts ubiquitin from the E1 complex and catalyses its covalent attachment to other proteins, including p53/TP53, PEX5 and CYP3A4. In vitro it catalyses 'Lys-48'-linked polyubiquitination and targets short-lived and abnormal proteins for degradation.
Aliases include UbcH5A, UBCH5, UBC4/5, E2(17)KB1 and SFT. Previous names are 'stimulator of Fe transport' and 'ubiquitin-conjugating enzyme E2D 1 (UBC4/5 homolog, yeast)'. Two transcript variants encoding different isoforms have been reported for the gene.
Mouse and rat both have an orthologous gene, Ube2d1; check the datasheet of any product for its validated reactivity. UBE2D1 is closely related to a stimulator of iron transport and is up-regulated in hereditary hemochromatosis. It also acts on p53 and HIF1alpha.
Other ubiquitin-conjugating E2 enzymes and related E3 ligase and ubiquitination-pathway targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P51668; product specifications from Assay Genie datasheets.